Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Sep 14 - Sep 19
Can I change my dosage time from morning to night
Retatrutide (LY3437943) is an investigational triple-hormone receptor agonist developed by Eli Lilly that targets the GIP, GLP-1, and glucagon receptors simultaneously
Arch Gen Psychiatry
Intense demand for new diet drugs is changing food consumption
In a news release, Nate Hill, the compounders CEO, characterized the lawsuit as a fight for the right of every patient to have access to the medicine their doctor prescribes, at a price that isnt dictated by a monopoly. The pharmaceutical companies have already responded to the competition by offering dramatically lower cash prices for their drugs, with Eli Lilly offering a starting dose of tirzepatide for $300 and Novo selling a starting dose of semaglutide for $350
Two completed Phase 3 trials confirm retatrutide's efficacy: TRIUMPH-4 showed 28.7% average weight loss at 68 weeks, and TRIUMPH-1 confirmed 28.3% in 2,339 general obesity patients at 80 weeks
US$ 20.90
US$ 25.12
US$ 27.14
US$ 21.79
